Antivirulence agents against MRSA

Future Medicinal Chemistry

Volumn 3, Issue 7, 2011, Pages 775-777

  Shoham, Menachem ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

antivirulence; MRSA; quorum sensing; resistance; Staphylococcus aureus; virulence

Indexed keywords

ALPHA HEMOLYSIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTIVIRULENCE AGENT; BETA CYCLODEXTRIN; DIFLUNISAL; HEMOGLOBIN; HLA ANTIBODY; PROTEIN HISTIDINE KINASE; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIAL ENDOCARDITIS; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; CHINESE MEDICINE; DRUG EFFICACY; DRUG TARGETING; HOST RESISTANCE; HUMAN; IMMUNOCOMPROMISED PATIENT; INFECTION PREVENTION; INNATE IMMUNITY; LUNG INJURY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANTI-BACTERIAL AGENTS; HEMOLYSIN PROTEINS; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; QUORUM SENSING; STAPHYLOCOCCAL INFECTIONS;

EID: 79958728656     PISSN: 17568919     EISSN: 17568927     Source Type: Journal    
DOI: 10.4155/fmc.11.43     Document Type: Review

References (21)

1. Kuehnert MJ. Methicillin-resistant-Staphylococcus aureus hospitalizations, United States. Emerg. Infect. Dis. 11(6), 868-872 (2005). (Pubitemid 40720847)
2. Klevens RM, Morrison MA, Nadle J et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298(15), 1763-1771 (2007). (Pubitemid 47598444)
3. Klein E, Smith DL, Laxminarayan R. Community-associated methicillin-resistant Staphylococcus aureus in outpatients, United States, 1999-2006. Emerg. Infect. Dis. 15(12), 1925-1930 (2009).
4. Gilbert DN, Guidos RJ, Boucher HW et al. The 10 × 20 initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020. Clin. Infect. Dis. 50(8), 1081-1083 (2010).
5. Rasko DA, Sperandio V. Anti-virulence strategies to combat bacteria-mediated disease. Nat. Rev. Drug Discov. 9(2), 117-128 (2010).
6. Cegelski L, Marshall GR, Eldridge GR, Hultgren SJ. The biology and future prospects of antivirulence therapies. Nat. Rev. Micro. 6(1), 17-27 (2008). (Pubitemid 350286217)
7. Queck SY, Jameson-Lee M, Villaruz AE et al. RNAIII-independent target gene control by the agr quorum-sensing system: insight into the evolution of virulence regulation in Staphylococcus aureus. Mol. Cell 32(1), 150-158 (2008).
8. George EA, Novick RP, Muir TW. Cyclic peptide inhibitors of Staphylococcal virulence prepared by Fmoc-based thiolactone peptide synthesis. JACS 130(14), 4914-4924 (2008). (Pubitemid 351500125)
9. Khodaverdian V, Pesho M, Truitt B, Bollinger L, Patel P, Shoham, M. Discovery of antipathogenic agents against MRSA. Presented at: Interscience Conference on Antimicrobial Agents and Chemotherapy Meeting. Boston, MA, USA, 12-15 September 2010.
10. Pishchany G, McCoy AL, Torres VJ et al. Specificity for human hemoglobin enhances Staphylococcus aureus infection. Cell Host Microbe 8(6), 544-550 (2010).
11. Kennedy AD, Bubeck Wardenburg J, Gardner DJ et al. Targeting of a-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model. J. Infect. Dis. 202(7), 1050-1058 (2010).
12. Ragle BE, Bubeck Wardenburg J. Anti-a- hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia. Infect. Immun. 77(7), 2712-2718 (2009).
13. Qiu J, Feng H, Lu J et al. Eugenol reduces the expression of virulence-related exoproteins in Staphylococcus aureus. Appl. Environ. Microbiol. 76(17), 5846-5851 (2010).
14. Qiu J, Feng H, Xiang H et al. Influence of subinhibitory concentrations of licochalcone A on the secretion of enterotoxins A and B by Staphylococcus aureus. FEMS Microbiol. Lett. 307(2), 135-141 (2010).
15. Qiu J, Wang D, Xiang H et al. Subinhibitory concentrations of thymol reduce enterotoxins A and B and a-hemolysin production in Staphylococcus aureus isolates. PLoS One 5(3), e9736 (2010).
16. Qiu J, Luo M, Dong J et al. Menthol diminishes Staphylococcus aureus virulence-associated extracellular proteins expression. Appl. Microbiol. Biotechnol. 90(2), 705-712 (2011).
17. Qiu J, Zhang X, Luo M et al. Subinhibitory concentrations of perilla oil affect the expression of secreted virulence factor genes in Staphylococcus aureus. PLoS One 6(1), e16160 (2011).
18. Xiang H, Qiu JZ, Wang DC, Jiang YS, Xia LJ, Deng XM. Influence of magnolol on the secretion of a-toxin by Staphylococcus aureus. Molecules 15(3), 1679-1689 (2010).
19. Ragle BE, Karginov VA, Bubeck Wardenburg J. Prevention and treatment of Staphylococcus aureus pneumonia with a b-cyclodextrin derivative. Antimicrob. Agents Chemother. 54(1), 298-304 (2010).
20. Montoya MT, Sliwinski J, Yeaman, MR, Bayer AS, Mercier RC. Diflunisal decreases S. aureus colonization and proliferation in an in vitro model of infective endocarditis. Presented at: Interscience Conference on Antimicrobial Agents and Chemotherapy Meeting. Boston, MA, USA, 12-15 September 2010.
21. Mark Stibich. MRSA Infection Statistics. http://longevity.about.com/od/ optimizemedicalcare/a/mrsa-infections-2.htm